Both in Pharmaceuticals
CAMP4 Therapeutics vs Standard BioTools
Over the past year CAMP returned −0.8% and LAB returned −50.4%; their daily moves had a correlation of 0.08.
CAMP −0.8% LAB −50.4%Growth of $1, one year, split-adjusted
| Metric | CAMP | LAB |
|---|---|---|
| Price | $3.91 | $0.6147 |
| Market cap | $245.4M | $242.6M |
| Today | +3.58% | +0.78% |
| 1 month | −2.5% | −19.4% |
| 6 months | −1.8% | −37.2% |
| Year to date | −36.2% | −52.0% |
| 1 year | −6.0% | −48.8% |
| Revenue growth (YoY) | +18.8% | −7.6% |
| Gross margin | 100.0% | 52.4% |
| Net margin | −1884.8% | −133.1% |
| P/E (TTM) | — | 2.9× |
| Price / sales | 58.2× | 2.9× |
| Net cash | $86.4M | $476.4M |
| Dividend yield | — | — |
| Volatility (60d) | 84.1% | 45.5% |
| Short % of float | 8.2% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).